 RedHill Biopharma Ltd NASDAQ: RDHL has entered into an exclusive license agreement with Kukbo Co Ltd for oral opaganib to treat COVID-19 in South Korea. Under the terms of the license agreement, which follows the previously announced strategic investment . 